Benefits of Prophylactic Proton Pump Inhibitors after Roux-en-Y Gastric Bypass Surgery: A Retrospective Study

Area of Science:

• Bariatric Surgery
• Gastroenterology
• Pharmacology

Background:

• Proton pump inhibitors (PPIs) are commonly prescribed post-Roux-en-Y gastric bypass (RYGB) to prevent marginal ulcers.
• The efficacy of PPIs as a prophylactic measure after RYGB remains under investigation.

Purpose of the Study:

• To retrospectively evaluate the prophylactic effectiveness of PPIs in preventing marginal ulcers following RYGB surgery.

Main Methods:

• A retrospective analysis of 200 patients undergoing RYGB between August 2012 and August 2013.
• Patients were divided into two groups: those receiving prophylactic PPIs and those who did not.
• Marginal ulcers were diagnosed via symptoms and confirmed by endoscopy.

Main Results:

• A total of 13 marginal ulcers were diagnosed in 200 patients over a mean follow-up of 6.7 months.
• While ulcers were less frequent in the PPI group, the difference was not statistically significant (p=0.200).
• Risk factors like nicotine, NSAIDs, and H. pylori did not significantly influence ulcer incidence.

Conclusions:

• The study suggests a potential benefit of PPIs in reducing marginal ulcers post-RYGB, but this was not statistically confirmed.
• Limitations include a small sample size and short follow-up period.
• Large-scale prospective studies are recommended to establish the definitive role of PPIs in RYGB patients.